Endometrial Infusion with Plasma Rich in Growth Factors (PRGF) in IVF Cycles: Randomized Clinical Trial in Very Thin Endometrium and Observational Uncontrolled Follow-Up After the Randomized Clinical Trial
Journal of Clinical Medicine · 13.03.2025 · 14 (6) · 1952
DOI: 10.3390/jcm14061952 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.03.2025. Verfasst von Ines Castells und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Valenciano de Infertilidad (IVI), IVIRMA, 48940 Bilbao, Spain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To assess if the instillation of plasma rich growth factors (PRGFs) improves endometrial thickness (EMT) in frozen embryo cycles performed under hormone treatment where the endometrium was very thin (≤5 mm).
Methods
First, a randomized controlled trial (RCT) was performed comparing women only receiving an increase in estrogen therapy (n = 9) and women receiving both the increase in estrogen therapy and three instillations of PRGF (n = 13). The second part of the study consisted of a prospective observational follow-up of the patients included in the RCT (for 1–3 months in the study group, and for 1–6 months in the control group).
Results
In the RCT, there was an increase in EMT in both the PRGF and control groups. However, the increase was significantly higher in the PRGF group (1.30 ± 0.67 mm) compared to the control group (0.58 ± 0.51 mm). In the PRGF group, 23% achieved an EMT of 7 mm compared to 0% in the control group. There were 2 pregnancies in the PRGF group resulting from the 3 transfers performed in that group. No transfer was carried out in the control group. There was a significant increase in EMT 1–3 months after the PRGF cycle. The live birth rate per transfer was 20% in the cycles following the PRGF cycles, whereas it was 30% per starting woman. For women in the control group who later underwent PRGF, the LBR was 57.1%.
Conclusions
PRGF instillation in cases of very thin endometrium increases EMT moderately. It is suggested that the beneficial effect of PRGF may persist for 1–3 cycles after instillation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto Valenciano de Infertilidad (IVI), IVIRMA, 48940 Bilbao, Spain.
- BTI-Biotechnology Institute ImasD, 01007 Vitoria-Gasteiz, Spain.
- University Institute for Regenerative Medicine & Oral Implantology, UIRMI (UPV/EHU-Fundación Eduardo Anitua), 01007 Vitoria-Gasteiz, Spain.
- Biobizkaia Health Research Institute, 48903 Baracaldo, Spain.
- Fundación IVI, IVIRMA, 46004 Valencia, Spain.
- Human Reproduction Unit, Cruces University Hospital, 48903 Baracaldo, Spain.
ORCID-Profile: María de la Fuente, Fernando Quintana, Eduardo Anitua, Roberto Matorras
Zitieren
APA
Castells, I., Ferrando, M., de la Fuente, M., Gantxegi, M., Quintana, F., Mascaros, J. M., Anitua, E., & Matorras, R. (2025). Endometrial Infusion with Plasma Rich in Growth Factors (PRGF) in IVF Cycles: Randomized Clinical Trial in Very Thin Endometrium and Observational Uncontrolled Follow-Up After the Randomized Clinical Trial. Journal of Clinical Medicine, 14(6), 1952. https://doi.org/10.3390/jcm14061952
Vancouver
Castells I, Ferrando M, de la Fuente M, Gantxegi M, Quintana F, Mascaros JM, et al. Endometrial Infusion with Plasma Rich in Growth Factors (PRGF) in IVF Cycles: Randomized Clinical Trial in Very Thin Endometrium and Observational Uncontrolled Follow-Up After the Randomized Clinical Trial. Journal of Clinical Medicine. 2025;14(6):1952. doi:10.3390/jcm14061952
BibTeX
@article{Castells2025,
author = {Castells, Ines and Ferrando, Marcos and de la Fuente, María and Gantxegi, Maitane and Quintana, Fernando and Mascaros, Juan Manuel and Anitua, Eduardo and Matorras, Roberto},
title = {Endometrial Infusion with Plasma Rich in Growth Factors (PRGF) in IVF Cycles: Randomized Clinical Trial in Very Thin Endometrium and Observational Uncontrolled Follow-Up After the Randomized Clinical Trial},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {6},
pages = {1952},
doi = {10.3390/jcm14061952}
}
EUVIMED